[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP3823593A4 - Compositions and methods for treating autism - Google Patents

Compositions and methods for treating autism Download PDF

Info

Publication number
EP3823593A4
EP3823593A4 EP19838884.5A EP19838884A EP3823593A4 EP 3823593 A4 EP3823593 A4 EP 3823593A4 EP 19838884 A EP19838884 A EP 19838884A EP 3823593 A4 EP3823593 A4 EP 3823593A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
treating autism
autism
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19838884.5A
Other languages
German (de)
French (fr)
Other versions
EP3823593A1 (en
Inventor
Steven Hoffman
John Rothman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamo Pharmaceuticals LLC
Original Assignee
Yamo Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/040,405 external-priority patent/US10813901B2/en
Application filed by Yamo Pharmaceuticals LLC filed Critical Yamo Pharmaceuticals LLC
Publication of EP3823593A1 publication Critical patent/EP3823593A1/en
Publication of EP3823593A4 publication Critical patent/EP3823593A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19838884.5A 2018-07-19 2019-07-03 Compositions and methods for treating autism Withdrawn EP3823593A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/040,405 US10813901B2 (en) 2013-10-22 2018-07-19 Compositions and methods for treating autism
PCT/US2019/040581 WO2020018292A1 (en) 2018-07-19 2019-07-03 Compositions and methods for treating autism

Publications (2)

Publication Number Publication Date
EP3823593A1 EP3823593A1 (en) 2021-05-26
EP3823593A4 true EP3823593A4 (en) 2022-04-20

Family

ID=69164567

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19838884.5A Withdrawn EP3823593A4 (en) 2018-07-19 2019-07-03 Compositions and methods for treating autism

Country Status (5)

Country Link
EP (1) EP3823593A4 (en)
JP (1) JP2021530569A (en)
CN (1) CN112822997A (en)
AU (1) AU2019308501A1 (en)
WO (1) WO2020018292A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020276605A1 (en) 2019-05-14 2022-01-20 Tyme, Inc. Compositions and methods for treating cancer
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015061328A2 (en) * 2013-10-22 2015-04-30 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US20160193169A1 (en) * 2013-10-22 2016-07-07 Steven Hoffman Compositions And Methods For Treating Intestinal Hyperpermeability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165382A (en) * 1977-10-17 1979-08-21 Jose Pozuelo Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
EP4438059A2 (en) * 2015-04-14 2024-10-02 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015061328A2 (en) * 2013-10-22 2015-04-30 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US20160193169A1 (en) * 2013-10-22 2016-07-07 Steven Hoffman Compositions And Methods For Treating Intestinal Hyperpermeability

Also Published As

Publication number Publication date
AU2019308501A1 (en) 2021-02-11
EP3823593A1 (en) 2021-05-26
JP2021530569A (en) 2021-11-11
WO2020018292A1 (en) 2020-01-23
CN112822997A (en) 2021-05-18

Similar Documents

Publication Publication Date Title
EP3947715A4 (en) Methods and compositions for treating cancer
EP3681525A4 (en) Composition and method for treating autism
EP3687981A4 (en) Compositions and methods for treating cancer
EP3612215A4 (en) Compositions and methods for treating lung inflammation
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
EP3423100A4 (en) Compositions for treating inflammation and methods of treating the same
EP3592345A4 (en) Compositions and methods for treating inflammatory diseases
EP3829299A4 (en) Bismuth-thiol compositions and methods for treating wounds
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP3700547A4 (en) Compositions and methods for treating liberibacter diseases and other bacterial diseases
EP3801478A4 (en) Methods and compositions for preventing or treating calciphylaxis
EP3836941A4 (en) Methods and compositions for treating mucositis
EP3600303A4 (en) Compositions, devices and methods for treating autism
EP3691649A4 (en) Compositions and methods for wound treatment
EP3893785A4 (en) Compositions and methods for treating wounds
EP3801620A4 (en) Compositions and methods for treating pancreatitis
EP3411367A4 (en) Compositions and methods for treating infections
EP3755328A4 (en) Compositions and methods for treating pruritus
EP3773585A4 (en) Compositions and methods for treating cancer
EP3727452A4 (en) Compositions and methods for treating neoplasia
EP3823593A4 (en) Compositions and methods for treating autism
AU2018301500A1 (en) Methods and compositions for treating inflammation
EP3595640A4 (en) Compositions and methods for treating multiple sclerosis
EP3672583A4 (en) Compositions and methods for treating neurodegenerative diseases

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0009000000

Ipc: A61K0031198000

A4 Supplementary search report drawn up and despatched

Effective date: 20220318

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/00 20060101ALI20220314BHEP

Ipc: A61K 31/4166 20060101ALI20220314BHEP

Ipc: A61K 31/55 20060101ALI20220314BHEP

Ipc: A61K 31/19 20060101ALI20220314BHEP

Ipc: A61K 9/00 20060101ALI20220314BHEP

Ipc: A61K 31/198 20060101AFI20220314BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230831

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240111